Notes - Segment Information, Etc.

KOBAYASHI PHARMACEUTICAL CO.,LTD. - Filing #7344479

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
172,793,000,000 JPY
662,000,000 JPY
173,455,000,000 JPY
JPY
130,497,000,000 JPY
173,455,000,000 JPY
42,295,000,000 JPY
125,980,000,000 JPY
39,676,000,000 JPY
601,000,000 JPY
JPY
166,258,000,000 JPY
166,258,000,000 JPY
165,657,000,000 JPY
Transactions with other segments
7,879,000,000 JPY
6,398,000,000 JPY
JPY
-14,277,000,000 JPY
6,041,000,000 JPY
14,277,000,000 JPY
1,837,000,000 JPY
4,655,000,000 JPY
1,877,000,000 JPY
6,243,000,000 JPY
-12,776,000,000 JPY
12,776,000,000 JPY
JPY
6,533,000,000 JPY
Other items
Depreciation
4,701,000,000 JPY
200,000,000 JPY
4,901,000,000 JPY
JPY
2,780,000,000 JPY
4,901,000,000 JPY
1,920,000,000 JPY
2,537,000,000 JPY
1,594,000,000 JPY
200,000,000 JPY
JPY
4,332,000,000 JPY
4,332,000,000 JPY
4,131,000,000 JPY
Increase in property, plant and equipment and intangible assets
25,646,000,000 JPY
266,000,000 JPY
26,887,000,000 JPY
973,000,000 JPY
8,415,000,000 JPY
25,913,000,000 JPY
17,231,000,000 JPY
11,407,000,000 JPY
3,076,000,000 JPY
197,000,000 JPY
1,112,000,000 JPY
14,681,000,000 JPY
15,794,000,000 JPY
14,484,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.